 result medic research council phase II studi low dose cisplatin methotrex primari treatment transit cell carcinoma bladder seri untreat patient categori bladder cancer underw treatment low dose methotrex cisplatin patient elig assess respons complet respons CR patient partial respons overal respons rate treatment major morbid treatment-rel death median follow-up year surviv rate patient recurrence-fre definit local therapi cystectomi radiotherapi follow-up month